Gotham Therapeutics
New York
About Gotham Therapeutics
Gotham Therapeutics is discovering a novel drug class targeting the epitranscriptomics machinery.The company offers treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $54.0M
- Funding stage: M&A
- Last round: Series A (Oct 2018)
- Website: gothamtx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/gotham-therapeutics-141096 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.